Choline-related supplements improve abnormal plasma methioninehomocysteine metabolites and glutathione status in children with cystic fibrosis

American Journal of Clinical Nutrition

Volumn 85, Issue 3, 2007, Pages 702-708

  Innis, Sheila M ^a,c   Davidson, A George F ^a   Melynk, Stepan ^b   James, S Jill ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Betaine; Choline; Cystic fibrosis; GSH:GSSG; Phospholipids; Ratio of glutathione to glutathione disulfide

Indexed keywords

ADENOSINE; ADENOSYLHOMOCYSTEINASE; BETAINE; CHOLINE; CYSTEINE; CYSTEINYLGLYCINE; FATTY ACID DERIVATIVE; GLUTATHIONE; GLUTATHIONE DISULFIDE; HOMOCYSTEINE; METHIONINE; PHOSPHATIDYLCHOLINE; S ADENOSYLMETHIONINE;

AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; HUMAN; MALE; PHOSPHOLIPID BLOOD LEVEL; SCHOOL CHILD; SUPPLEMENTATION;

EID: 33847776504     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/85.3.702     Document Type: Article

References (50)

1. Bradbury NA. Intracellular CFTR. Localization and function. Physiol Rev 1999;79(suppl):S175-91.
2. Rommens JM, Iannuzzi MC, Kerem B, et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989;245:1059-65.
3. Reisin IL, Prat AG, Abraham EH, et al. The cystic fibrosis transmembrane conductance regulator is a dual ATP and chloride channel. J Biol Chem 1994;269:20584-91.
4. Schwiebert EM, Egan ME, Hwang TH, et al. CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP. Cell 1995;81:1063-73.
5. Davidson AGF. Gastrointestinal and pancreatic disease in cystic fibrosis. In: Hodson ME, Geddes DM, eds. Cystic fibrosis. 2nd ed. London, United Kingdom: Chapman & Hall, 2000:384-95.
6. Chen AH, Innis SM, Davidson AGF, James SJ. Phosphatidylcholine and lysophosphatidylcholine excretion is increased in children with cystic fibrosis and is associated with plasma homocysteine, S-adenosylhomocysteine, and S-adenosylmethionine. Am J Clin Nutr 2005;81:686-91.
7. Barraclough M, Taylor CJ. Twenty-four hour ambulatory gastric and duodenal pH profiles in cystic fibrosis: effect of duodenal hyperacidity on pancreatic enzyme function and fat absorption. J Pediatr Gastroenterol Nutr 1996;23:45-50.
8. Francisco MP, Wagner MH, Sherman JM, Theriaque D, Bowser E, Novak DA. Ranitidine and omeprazole as adjuvant therapy to pancrelipase to improve fat absorption in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 2002;35:79-83.
9. Proesmans M, De Boeck K. Omeprazole, a proton pump inhibitor, improves residual steatorrhea in cystic fibrosis patients treated with high dose pancreatic enzymes. Eur J Pediatr 2003;162:760-3.
10. Colombo C, Battezzati PM, Strazzabosco M, Podda M. Liver and biliary problems in cystic fibrosis. Semin Liver Dis 1998;18:227-35.
11. Westaby D. Liver and biliary disease in cystic fibrosis. In: Hodson ME, Geddes DM, eds. Cystic fibrosis. 2nd ed. London, United Kingdom: Chapman & Hall, 2000:289-300.
12. Lindblad A, Hultcrantz R, Strandvik B. Bile-duct ligation and collagen deposition: a prominent ultrastructural feature of the liver in cystic fibrosis. Hepatology 1992;16:372-81.
13. Benabdeslam H, Abidi H, Garcia I, Bellon G, Gilly R, Revol A. Lipid peroxidation and antioxidant defenses in cystic fibrosis patients. Clin Chem Lab Med 1999;37:511-6.
14. Brown RK, Kelly FJ. Evidence for increased oxidative stress in patients with cystic fibrosis. Pediatr Res 1994;36:487-93.
15. Gao L, Kim KJ, Yankaskas JR, Forman HJ. Abnormal glutathionine transport in cystic fibrosis airway epithelia. Am J Physiol 1999;277:L113-8.
16. Hudson VM. Rethinking cystic fibrosis pathology: the critical role of abnormal reduced glutathione (GSH) transport caused by CFTR mutation. Free Radical Biol Med 2001;30:1440-61.
17. Lindsell P, Harahan JW. Glutathionine permeability of CFTR. Am J Physiol 1988;275:L323- 6.
18. Winklhofer-Roob BM. Oxygen free radicals and antioxidants in cystic fibrosis: the concept of an oxidant-antioxidant imbalance. Acta Paediatr Suppl 1994;83:49-57.
19. Vance DE. Phosphatidylcholine metabolism: masochistic enzymology, metabolic regulation, and lipoprotein assembly. Biochem Cell Biol 1990;68:1151-65.
20. Yao ZM, Vance DE. The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes. J Biol Chem 1988;263:2998-3004.
21. Wu G, Fang Y-Z, Yang S, Lupton J, Turner ND. Glutathione metabolism and its implications for health. J Nutr 2004;134:489-92.
22. Grattagliano I, Caraceni P, Portincasa P, et al. Adaptation of subcellular glutathione detoxification system to stress conditions in choline-deficient diet induced rat fatty liver. Cell Biol Toxicol 2003;19:355-66.
23. Arvidson GA, Asp NG. Hepatic free choline and betaine and the utilization of dietary protein in the choline-deficient rat. Ann Nutr Metab 1982;26:12-7.
24. Vance DE, Walkey CJ, Cui Z. Phosphatidylethanolamine N- methyltransferase from liver. Biochim Biophys Acta 1997;4:142-50.
25. Fowler B. Homocysteine: overview of biochemistry, molecular biology, and role in disease processes. Semin Vasc Med 2005;5:77-86.
26. Niculescu MD, Zeisel SH. Diet, methyl donors and DNA methylation: interactions between dietary folate, methionine and choline. J Nutr 2002;132(suppl):2333S-5S.
27. Zou C-G, Banerjee R. Homocysteine and redox signaling. Antioxid Redox Signal 2005;7:547-59.
28. Innis SM, Davidson AGF, Chen A, Dyer RA, Melnyk S, James J. Increased plasma homocysteine and s-adenosylhomocysteine and decreased methionine is associated with altered phosphatidylcholine and phosphatidylethanolamine in cystic fibrosis. J Pediatr 2003;143:351-6.
29. Innis SM, Hasman D. Evidence of choline depletion in children with cystic fibrosis associated with reduced betaine dependent remethylation of homocysteine. J Nutr 2006;136:2226-31.
30. Institute of Medicine. Dietary reference intakes for thiamine, riboflavin, niacin, vitamin B6, folate B12, pantothenic acid, biotin and choline. Washington, DC: National Academy Press, 2000:390-422.
31. Thompson Micromedex Healthcare Systems Integrated Index. Internet: http://micromedex.phsa.ca/mdxcgi/display.exe?CTL=E:\netpub\micromedex\mdx\ mdxcgi\MEGAT.SYS&SET=1C6543BD25BAB4A0&SYS=1&T=244&M=316112 (accessed March 2006).
32. Innis SM, Dyer RA. Brain astrocyte synthesis of docosahexaenoic acid from n-3 fatty acids is limited at the elongation of docosapentaenoic acid. J Lipid Res 2002;43:1529-36.
33. Elias SL, Innis SM. Infant plasma trans, n-6, and n-3 fatty acids and conjugated linoleic acids are related to maternal plasma fatty acids, length of gestation, and birth weight and length. Am J Clin Nutr 2001;73:807-14.
34. Melnyk S, Pogribna M, Pogribny I, Hine RJ, James SJ. A new HPLC method for the simultaneous determination of oxidized and reduced plasma aminothiols using coulometric electrochemical detection. J Nutr Biochem 1999;10:490-7.
35. Melnyk S, Pogribna M, Pogribny IP, Yi P, James SJ. Measurement of plasma and intracellular S-adenosylhomocysteine and S-adenosylhomocysteine utilizing coulometric electrochemical detection: alterations with plasma homocysteine and pyridoxal-5-phosphate levels. Clin Chem 2000;46:265-72.
36. Rasmussen K, Moller J. Total homocysteine measurement in clinical practice. Arch Clin Biochem 2000;37:627-48.
37. Jacobs RL, Stead LM, Devlin C, et al. Physiological regulation of phospholipid methylation alters plasma homocysteine in mice. J Biol Chem 2005;280:28299-305.
38. Shields DJ, Lingrell S, Agellon LB, Brasnan JT, Vance DE. Localization independent regulation of homocysteine secretion by phosphatidylethanolamine N-methyltransferase. J Biol Chem 2005;220:27339-44.
39. Noya AA, Stead LM, Zhao Y, Brosnan ME, Brosnan JT, Vance DE. Plasma homocysteine is regulated by phospholipid methylation. J Biol Chem 2003;278:5452-5.
40. Hoffman DR, Haning JA, Cornatzer WE. Microsomal phosphatidylethanolamine methyltransferase: inhibition by S-adenosylhomocysteine. Lipids 1981;16:561-7.
41. Baric I, Fumic K, Glenn B, et al. S-adenosylhomocysteine hydrolase deficiency in a human: a genetic disorder of methionine metabolism. Proc Natl Acad Sci U S A 2004;10:4234-9.
42. Zeisel SH, Zola T, daCosta KA, Pomfret EA. Effect of choline deficiency on S-adenosylmethionine and methionine concentrations in rat liver. J Biochem 1989;259:725-9.
43. Melse-Boonstra A, Holm PI, Meland PM, Olthof M, Clarke R, Verhoef P. Betaine concentration as a determinant of fasting total homocysteine concentrations and the effect of folic acid supplementation on betaine concentrations. Am J Clin Nutr 2005;81:1378-82.
44. Verhoef P, de Groot LC. Dietary determinants of plasma homocysteine concentrations. Semin Vasc Med 2005;5:110-23.
45. Chen A, Innis SM. Assessment of phospholipid malabsorption by quantification of fecal phospholipid. J Pediatr Gastroenterol Nutr 2004;39:85-91.
46. Kim SK, Kim YC. Effects of betaine supplementation on hepatic metabolism of sulphur-containing amino acids in mice. J Hepatol 2005;42:907-13.
47. Smolin LA, Benevenga NJ, Berlow A. The use of betaine for the treatment of homocysteinuria. J Pediatr 1981;99:467-72.
48. Hartl D, Starosta V, Maier K, et al. Inhaled glutathione decreases PGE2 and increases lymphocytes in cystic fibrosis lungs. Free Radic Biol Med 2005;39:463-72.
49. Bishop C, Hudson VM, Hilton SC, Wilde C. A pilot study of the effect of inhaled glutathione on the district state of patients with cystic fibrosis. Chest 2005;127:12-4.
50. Deneke SM. Thiol-based anti-oxidants. Curr Top Cell Regul 2000;36:151-80.